Editorial: “Wildcatting” for Breakthroughs in Urothelial Cancer Detection and Management-Frustrating Business
- 1 October 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 154 (4), 1348-1350
- https://doi.org/10.1016/s0022-5347(01)66858-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Tumor Suppressor Gene Alterations in Bladder CarcinomaSurgical Oncology Clinics of North America, 1995
- Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentationsUrology, 1995
- Absolute concentration of urinary endogenous β‐glucuronidase determined by an ELISA method as a sensitive but non‐specific indicator for active renal parenchymal damageBritish Journal of Urology, 1995
- Accumulation of Nuclear p53 and Tumor Progression in Bladder CancerNew England Journal of Medicine, 1994
- Comparison of two routes of photosensitizer administration for photodynamic therapy of bladder cancerUrological Research, 1994
- Radical Cystectomy for Stages TA, TIS and T1 Transitional Cell Carcinoma of the BladderJournal of Urology, 1994
- Home Screening for Hematuria: Results of a Multi-Clinic StudyJournal of Urology, 1992
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.Journal of Clinical Oncology, 1988
- Urinary -glucuronidase activity in renal diseaseArchives of Internal Medicine, 1973